Amarin Corp Plc (AMRN)

[HDGabor]

N-

I didn't see a single reference to ongoing litigation?

FYI

Hikma launched generic IPE in Nov’20
? Thus far, generic supply appears limited
? Indication is only for TG >500 mg/dL
? Net pricing of generic is higher than branded
VASCEPA for many payers and patients
(WAC price is 12.3% below branded
VASCEPA, rebate levels to many payers
exceed this WAC price difference)

No other generic launched
? Dr. Reddy’s Labs and Teva received FDA
approval for generic IPE in May’20 and
Aug’20, respectively
? Apotex ANDA currently not approved

Amarin pursuing various legal actions to enforce
its rights, including infringement lawsuit filed
against Hikma in Nov’20 and expanded in Jan’21
to include payer, HealthNet

TG >500 mg/dL indication is not being pursued in
Europe and various other markets to avoid
potential generic entry for skinny label

Best,
G